Related Experiment Video
Updated: Dec 25, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Preparation, characterization and preliminary in vivo studies of inactivated SARS-CoV vaccine
Lin Tang1, Jian Wang1, Ede Qin2
11Beijing Genomics Institute, Chinese Academy of Sciences, 101300 Beijing, China.
Abstract:
A large quantity of SARS-CoV virus was proliferated in Vero cells, inactivated with β-propiolactone, then purified by Sepharose 4FF column chromatography to prepare inactivated vaccine. The vaccine was identified by Western blot, mass spectrographic analysis, ELISA and electron microscopy. The vaccine with or without aluminum hydroxide adjuvant was inoculated into female BALB/c mice at different dosages. The result showed that the antibodies to SARS-CoV were induced in the mice. The antibody levels induced by the vaccine with aluminum hydroxide were higher than those without aluminum hydroxide.
More Related Videos
Related Concept Videos
Preclinical Development: Overview
Vaccinations

